- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.08. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 21.07. | NSE - IMAC Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| 19.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 12.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.07. | IMAC Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.06. | IMAC Holdings, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 30.06. | IMAC Holdings, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
| 18.06. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.05. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.05. | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 02.05. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.04. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 03.04. | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 31.03. | IMAC Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 25.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.03. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.02. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.02. | IMAC Holdings, Inc.: Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,574 | 0,00 % | Plus Therapeutics files to sell 33M shares of common stock for holders | ||
| LIFEWARD | 0,709 | 0,00 % | Lifeward Ltd.: Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| EKSO BIONICS | 3,190 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 5,600 | -2,44 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,853 | -4,53 % | Rockwell Medical Non-GAAP EPS of -$0.01, revenue of $16.07M misses by $0.26M | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 16,365 | +1,58 % | These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results | ||
| SINTX TECHNOLOGIES | 3,050 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | New leadership and recapitalization to accelerate commercialization of proprietary silicon nitride technologies in medical and high-growth markets SALT LAKE CITY, Utah, June 12, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| AETHLON MEDICAL | 1,430 | -100,00 % | Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update | Australian Cancer Trial Advances with First Cohort Complete, Amended Protocol, and Promising Preclinical Data Published; Operating Expenses Cut by 32%
Conference... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences downgraded to NEX | ||
| NEURONETICS | 3,355 | +1,21 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| HVIVO | 0,107 | 0,00 % | hVIVO PLC - Proposed appointment of Chair | ||
| PRIVIA HEALTH GROUP | 21,020 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen |
Das Unternehmen IMAC HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,008 (-4,00 %) liegt der Kurs bei 0,192 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.